Journal of Kermanshah University of Medical Sciences
Peer-reviewed Medical Quarterly
Image Credit:J Kermanshah Univ Med Sci
Outline
New Challenges of COVID-19 Vaccine Booster Dose Hesitancy in Iran
Authors
Footnotes
Authors' Contribution: Conceptualization: M.R. Writing-original draft: S.H., M.R.
Conflict of Interests: The authors declare that they have no conflict of interest in this letter.
Funding/Support: This letter received no specific grant from any funding agency in public, commercial, or not-for-profit sectors.
References
- 1.Ghazy RM, Abdou MS, Awaidy S, Sallam M, Elbarazi I, Youssef N, et al. Acceptance of COVID-19 Vaccine Booster Doses Using the Health Belief Model: A Cross-Sectional Study in Low-Middle- and High-Income Countries of the East Mediterranean Region. Int J Environ Res Public Health. 2022;19(19). [PubMed ID: 36231447]. [PubMed Central ID: PMC9566578]. https://doi.org/10.3390/ijerph191912136.
- 2.Wong LP, Alias H, Danaee M, Ahmed J, Lachyan A, Cai CZ, et al. COVID-19 vaccination intention and vaccine characteristics influencing vaccination acceptance: a global survey of 17 countries. Infect Dis Poverty. 2021;10(1):122. [PubMed ID: 34620243]. [PubMed Central ID: PMC8496428]. https://doi.org/10.1186/s40249-021-00900-w.
- 3.Iran (Islamic Republic of), WHO (COVID-19) dashboard. World Health Organization; 2023. Available from: https://covid19.who.int/region/emro/country/ir.
- 4.Omidvar S, Firouzbakht M. Acceptance of COVID-19 vaccine and determinant factors in the Iranian population: a web-based study. BMC Health Serv Res. 2022;22(1):652. [PubMed ID: 35578251]. [PubMed Central ID: PMC9108146]. https://doi.org/10.1186/s12913-022-07948-w.
- 5.Hosseinzadeh A, Sahab-Negah S, Nili S, Aliyari R, Goli S, Fereidouni M, et al. COVID-19 cases, hospitalizations and deaths after vaccination: a cohort event monitoring study, Islamic Republic of Iran. Bull World Health Organ. 2022;100(8):474-83. [PubMed ID: 35923277]. [PubMed Central ID: PMC9306382]. https://doi.org/10.2471/BLT.22.288073.
Copyright
Copyright © 2023, Journal of Kermanshah University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Similar Articles
COVID-19 Vaccines in Iran
Safarzadeh Kozani P, Safarzadeh Kozani P, Mirarefin SMJ, Sheikhi S, Baharifar N, et al. COVID-19 Vaccines in Iran. J Adv Immunopharmacol. 2022;2(2):e127067. doi: https://doi.org/10.5812/tms-127067
The Effectiveness of COVID -19 Vaccine for Immunocompromised Adults During Omicron Predominance
Mardani M. The Effectiveness of COVID -19 Vaccine for Immunocompromised Adults During Omicron Predominance. Arch Clin Infect Dis. 2023;17(6):e135133. doi: https://doi.org/10.5812/archcid-135133
Achieving Vaccine for COVID-19: Hope for AIDS and Hepatitis C Vaccine?
Ghelichi-Ghojogh M, Valizadeh R, Nozad P, Khezri R. Achieving Vaccine for COVID-19: Hope for AIDS and Hepatitis C Vaccine?. J Cell Mol Anesth. 2021;6(1):e151497. doi: https://doi.org/10.22037/jcma.v6i1.34265
Opportunities and Threats: The Necessity of Research in Dealing with the Rapid Spread of Coronavirus disease 2019 (COVID-19) in Iran
Naser Moghadasi A. Opportunities and Threats: The Necessity of Research in Dealing with the Rapid Spread of Coronavirus disease 2019 (COVID-19) in Iran. Arch Clin Infect Dis. 2020;15(COVID-19):e102809. doi: https://doi.org/10.5812/archcid.102809
The Impact of COVID-19 Immunity in Vaccine Development
Mardani M. The Impact of COVID-19 Immunity in Vaccine Development. Arch Clin Infect Dis. 2020;15(3):e109880. doi: https://doi.org/10.5812/archcid.109880
- Scopus by DOI: 0
Last Update: 2 weeks ago
- Scopus by Title: 0
Last Update: 2 weeks ago
- Scopus by Title (Ref): 1
Last Update: 2 weeks ago
- CrossRef: 1
Last Update: 1 hour ago
- OpenAlex: 2
Last Update: 1 day ago
- OpenCitations: 2
Last Update: 4 days ago